ANGPTL4 may play a role in creating a feedback loop that supports pancreatic cancer progression, while the down-regulation of the ECM protein LAMA2 is likely associated with pancreatic cancer advancement. Here, ANGPTL4 is linked to familial pancreatic carcinoma.